CAS NO: | 200940-22-3 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | SB 243213 is an orally active, selective and high-affinity5-HT2Creceptorantagonist with apKiof 9.37 and apKbof 9.8 for human 5-HT2Creceptor. SB 243213 shows greater than a 100-fold selectivity over a wide range of neurotransmitter receptors, enzymes and ion channels. SB 243213 has improved anxiolytic profile and has the potential for schizophrenia and motor disorders[1]. | ||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||
体外研究 (In Vitro) | SB 243213 shows little affinity (pKi<6) for cloned human 5-HT1A, 5-HT1B, 5-HT1E, 5- HT1Fand 5-HT7receptors. It shows weak affinity (pKi<6.5) for the cloned human 5-HT1Dand D3 receptors and moderate affinity (pKi=6.7) for the cloned human D2 receptor[1]. | ||||||||||||||||
体内研究 (In Vivo) | SB 243213 (0.1-10 mg/kg, p.o. 1 h pre-test) dose-dependently and significantly increases the amount of time rats spent in social interaction over 15 min under brightly lit conditions and in an unfamiliar test box[1].
| ||||||||||||||||
分子量 | 428.41 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C22H19F3N4O2 | ||||||||||||||||
CAS 号 | 200940-22-3 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 125 mg/mL(291.78 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |